ClinicalTrials.Veeva

Menu

Dosimetric Limitation of Pelvic Bone and Peritoneal Space in Rectal Cancer Patients During Chemoradiotherapy

Fudan University logo

Fudan University

Status

Active, not recruiting

Conditions

Rectal Cancer

Treatments

Radiation: dosimetric limitation of pelvic bone and peritoneal space during radiotherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT05688033
IMRTGI0001

Details and patient eligibility

About

This project first retrospectively analyzes the intestinal dose indicators related to the concurrent radiotherapy and chemotherapy of rectal cancer and gastrointestinal toxicity, and the pelvic dose indicators related to hematological toxicity, and then prospectively conducts radiotherapy based on the dose indicators most closely related to toxicity. The dose is limited when the plan is made to reduce the gastrointestinal and hematological toxicity of rectal cancer with concurrent radiotherapy and chemotherapy.

Enrollment

200 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients with rectal adenocarcinoma
  2. Clinical staged T3/4 or any node-positive disease
  3. Age of 18-75 years
  4. Karnofsky Performance Status > 80
  5. Adequate bone marrow reserve, renal and hepatic functions
  6. Without previous antitumoural chemotherapy
  7. No evidence of metastatic disease
  8. Written informed consent before randomization
  9. UGT1A1's genotype of 6/6 or 6/7

Exclusion criteria

  1. Clinical staged I or IV
  2. Age of <18 or >75 years
  3. Karnofsky Performance Status < 80
  4. Previous pelvis radiotherapy
  5. Previous antitumoural chemotherapy
  6. Clinically significant internal disease
  7. Refuse to write informed consent before randomization
  8. UGT1A1's genotype of 7/7

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 2 patient groups

experimental arm
Experimental group
Description:
peritoneal space V15\<850cc,pelvic bone V10\<80% and normal dosimetric limitation
Treatment:
Radiation: dosimetric limitation of pelvic bone and peritoneal space during radiotherapy
control arm
No Intervention group
Description:
normal dosimetric limitation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems